Dimed Distribuidora de Medicamentos (BSP:PNVL3) 3-Year EBITDA Growth Rate : 24.90% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos 3-Year EBITDA Growth Rate?

Dimed Distribuidora de Medicamentos's EBITDA per Share for the three months ended in Dec. 2023 was R$0.70.

During the past 12 months, Dimed Distribuidora de Medicamentos's average EBITDA Per Share Growth Rate was 18.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 24.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 20.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 38.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Dimed Distribuidora de Medicamentos was 889.20% per year. The lowest was -87.80% per year. And the median was 15.30% per year.

Competitive Comparison of Dimed Distribuidora de Medicamentos's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dimed Distribuidora de Medicamentos's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's 3-Year EBITDA Growth Rate falls into.

Dimed Distribuidora de Medicamentos 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Dimed Distribuidora de Medicamentos (BSP:PNVL3) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Dimed Distribuidora de Medicamentos 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Dimed Distribuidora de Medicamentos's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000

Website

https://www.grupopanvel.com.br

Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Headlines

No Headlines